Overall Survival of Triple Class Refractory, Penta-Exposed Multiple Myeloma (MM) Patients Treated with Selinexor Plus Dexamethasone or Conventional Care: A Combined Analysis of the STORM and Mammoth Studies
Year: 2019
Type: conference-abstract
Source: Blood
Authors: Luciano J. Costa, Parameswaran Hari, Shaji K. Kumar, Shijie Tang, Ujjawal H Gandhi, Jatin J. Shah, Sundar Jagannath, Ajai Chari, Arjun Lakshman, Sharon Shacham, Xiwen Ma, David S. Siegel, Noa Biran, Sagar Lonial, Paul G. Richardson, Michael G. Kauffman, Ehsan Malek, Kelly N. Godby, Mark A. Fiala, Saurabh Chhabra, Saad Z. Usmani, Natalie Scott Callander, Yubin Kang, Amarendra K. Neppalli, Elvira Umyarova, Robert F. Cornell
Institutions: University of Alabama at Birmingham, Medical College of Wisconsin, Mayo Clinic, Karyopharm Therapeutics (United States), Vanderbilt University, Vanderbilt University Medical Center, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, University of Pittsburgh Medical Center, Hackensack University Medical Center, Mount Sinai Hospital, Hackensack Meridian Health, Emory University, Winship Cancer Institute, Dana-Farber Cancer Institute, University Hospitals Seidman Cancer Center, Washington University in St. Louis, Medical University of South Carolina, Levine Cancer Institute, University of Wisconsin–Madison, Duke University, Duke Medical Center, MUSC Hollings Cancer Center, University of Vermont Medical Center
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2987028072